Privacy Policy
Signals Blog

Contributors

Categories

Communicating new science in a crisis

On most days, scientific discoveries are not cover stories or even top headlines. That hasn’t been the case since COVID-19 hit our collective consciousness. We are being inundated with science news, which would be great under different circumstances. But communicating...

Cell therapies: how much will we pay?

Dr. Chih Wei Teng is Chief Operating Officer for CCRM Australia and wrote this blog with colleagues Alex Barrington and Dr. Emma Gallaher. To subscribe to the CCRM Australia newsletter: Click here  As stem cell therapies move through clinical trials and get closer to...

Info for all, minus the paywall

Joshua Dierolf (www.joshuadierolf.com) is a PhD candidate at Western University studying the influence of metabolism on stem cell pluripotency and early development. It is hard to evade the incessant bombardment of social media pseudoscience. Like most things in life,...

TMM 2019: Activating women’s voices and promoting equity

This cartoon from 1988, drawn by Riana Duncan for Punch, was included in a talk titled “In Search of the Lehman Sisters: Why Your Insights are Needed,” by Shari Graydon, Founder of Informed Opinions, at a “Women in Regenerative Medicine Luncheon” at the 2019 Till...

Effective workshop structure: Exploiting the ties that bind

In October, I participated in a workshop hosted by Medicine by Design (MbD) in Toronto. The workshop was right up my alley – blood stem cells and clonal evolution – but I’ll spare the Signals readership the specific details.* Rather, today’s post focuses...

Summer by Design: Filling in the gap between academia and industry

Virginia Palomares Cabeza is a fourth-year PhD candidate at the Erasmus Medical Centre (Rotterdam, the Netherlands) and the University College Dublin (Ireland). Her interdisciplinary research focuses on investigating the immune responses of allogeneic stem cell...